Iesato, A., Suzuka, J., Otsuji, K., Osako, T., Yamashita, N., Inoue, Y., Maeda, T., Uehiro, N., Yoshida, K., Takahashi, Y., Kumegawa, K., Saeki, S., Yang, L., Tsuchiya, A., Sakiyama, K., Tanaka, M., Sakai, T., Ohno, S., Noda, T., Ueno, T. and Maruyama, R. Axillary adipose tissue-derived lymphatic endothelial cells exhibit distinct transcriptomic signatures reflecting lymphatic invasion status in breast cancer.
Breast Cancer Res., 27, 109 (2025) |
Wang, W., Kumegawa, K., Chapman, O. S., Shiraishi, R., Xiao, Z., Okonechnikov, K., Sun, Y., Pfister, S. M., Feng, W., Uesaka, N., Hoshino, M., Takahashi, S., Korshunov, A., Chavez, L., Maruyama, R. and Kawauchi, D. Chromatin Modification Abnormalities by CHD7 and KMT2C Loss Promote Medulloblastoma Progression.
Cell Rep., 44, 115673 (2025) |
Ogawa, A., Izumikawa, K., Tate, S., Isoyama, S., Mori, M., Fujiwara, K., Watanabe, S., Ohga, T., Jo, U., Taniyama, D., Kitajima, S., Tanaka, S., Onji, H., Kageyama, S.-I., Yamamoto, G., Saito, H., Morita, T. Y., Okada, M., Natsumeda, M., Nagahama, M., Kobayashi, J., Ohashi, A., Sasanuma, H., Higashiyama, S., Dan, S., Pommier, Y. and Murai, J. SLFN11-mediated ribosome biogenesis impairment induces TP53-independent apoptosis.
Mol. Cell, in press (2025) |
Utsumi, T., Mizuta, H., Seto, Y., Uchibori, K., Nishio, M., Okamoto, I. and Katayama, R. AXL-mediated drug resistance in ALK-rearranged NSCLC enhanced by GAS6 from macrophages and MMP11 positive fibroblasts.
Cancer Sci., in press (2025) |
Maruyama, K., Shimizu, Y., Nomura, Y., Oh-hara, T., Takahashi, Y., Nagayama, S., Fujita, N. and Katayama, R. Mechanisms of KRAS inhibitor resistance in KRAS-mutant colorectal cancer harboring Her2 amplification and aberrant KRAS localization.
npj Precis Oncol, in press (2025) |
Sasaki, N., Homme, M., Murayama, T., Osaki, T., Tenma, T., An, T., Takegami, Y., Tani, T., Gedeon, P. C., Kobayashi, Y., Cañadas, I., Barbie, D. A., Yao, R. and Kitajima, S. RNA sensing induced by chromosome missegregation augments anti-tumor immunity.
Mol. Cell, in press (2024) |
Fujimura, T., Furugaki, K., Mizuta, H., Muraoka, S., Nishio, M., Adachi, J., Uchibori, K., Miyauchi, E., Hayashi, H., Katayama, R. and Yoshiura, S. Targeting ErbB and tankyrase1/2 prevent the emergence of drug-tolerant persister cells in ALK-positive lung cancer.
NPJ Precis. Oncol., 264, in press (2024)
|
Sakimoto, Y., Kumegawa, K., Matsui, S., Yamaguchi, T., Mukai, T., Okabayashi, K., Mori, S., Kitagawa, Y., Akiyoshi, T. and Maruyama, R. Single-cell RNA-seq analysis of cancer-endothelial cell interactions in primary tumor and peritoneal metastasis from a single patient with colorectal cancer.
BJC Reports, 2, 88 (2024) |
Okazaki, F., Yorozu, A., Sekiguchi, S., Niinuma, T., Maruyama, R., Kitajima, H., Yamamoto, E., Ishiguro, K., Toyota, M., Hatanaka, Y., Nishiyama, K., Ogi, K., Kai, M., Takano, K., Ichimiya, S., Miyazaki, A. and Suzuki, H. AEBP1 is a negative regulator of skeletal muscle cell differentiation in oral squamous cell carcinoma.
Sci. Rep., 14, 27425 (2024) |
Watanabe, K., Yamamoto, T., Fujita, T., Hino, S., Hino, Y., Yamazaki, K., Ohashi, Y., Sakuraba, S., Kono, H., Nakao, M., Ochiai, K., Dan, S. and Saitoh, N. Metabolically inducing defects in DNA repair sensitizes BRCA–wild-type cancer cells to replication stress.
Science signaling, 17, in press (2024)
|
